share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4:持股變動聲明-董事 Borgeson Blake
美股sec公告 ·  06/13 17:40
Moomoo AI 已提取核心訊息
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 11, 2024. The shares were sold at a price of $8.4531 per share, resulting in a total transaction value of approximately $96,762.64. Following the transaction, Borgeson directly holds a total of 7,188,563 shares in the company. The sale was conducted in the open market.
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 11, 2024. The shares were sold at a price of $8.4531 per share, resulting in a total transaction value of approximately $96,762.64. Following the transaction, Borgeson directly holds a total of 7,188,563 shares in the company. The sale was conducted in the open market.
與Recursion Pharmaceuticals, Inc. [RXRX]相關的報告人Blake Borgeson於2024年6月11日完成了銷售11,447股A類普通股的交易。這些股票以8.4531美元的價格出售,交易總價值約爲96,762.64美元。交易後,Borgeson直接持有該公司的7,188,563股股份。此次交易是在公開市場上進行的。
與Recursion Pharmaceuticals, Inc. [RXRX]相關的報告人Blake Borgeson於2024年6月11日完成了銷售11,447股A類普通股的交易。這些股票以8.4531美元的價格出售,交易總價值約爲96,762.64美元。交易後,Borgeson直接持有該公司的7,188,563股股份。此次交易是在公開市場上進行的。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息